Navigation Links
Acutus Medical, Inc. Initiates "First-In-Man" Clinical Study of Real-Time 3D Imaging Catheter with CT/MRI Quality
Date:4/30/2013

SAN DIEGO, April 30, 2013 /PRNewswire/ -- Acutus Medical, Inc. (ACM or Company), an emerging developer and manufacturer of medical devices designed to provide real-time 3D cardiac electrical mapping based on dipole density for the treatment of cardiac arrhythmias, announced today that it has performed its First-In-Man clinical study of its cardiac catheter to provide highest-quality real-time 3D mapping of the human heart.

(Logo: http://photos.prnewswire.com/prnh/20130430/LA01948LOGO)

The first four patient procedures were performed by Principal Investigator Professor Mattias Duytschaever , MD, at Sint-Jan Hospital in Brugge, Belgium.

"We are very pleased with the progress of our First-In-Man clinical study and we look forward to the forthcoming studies for our technology in the European markets" said Randy Werneth , CEO/President. "We have the ability in a matter of seconds to generate real-time 3D images of the heart with quality equivalent to a CT or MRI."

About Acutus Medical
Since June, 2011, Acutus Medical has pioneered a new and novel approach in the minimally invasive imaging and mapping of cardiac arrhythmias. 

Acutus Medical has concentrated its efforts on the developing its technology for the treatment of an aberrant arrhythmia, atrial fibrillation (AF). Acutus Medical believes that its technology may eventually play a significant role in improving the lives of countless individuals who are afflicted by AF.

This press release includes forward-looking statements regarding Acutus Medical Cardiac Imaging and Mapping Technology System. Any statement describing Acutus Medical's goals, expectations, intentions or beliefs is a forward-looking statement and should be considered an at-risk statement, including those statements that are described as Acutus goals. Such statements are subject to certain risks and uncertainties, particularly those inherent in the process of discovering, developing and commercializing products and in the endeavor of building a business around such products. Acutus Medical's forward-looking statements also involve assumptions that, if they never materialize or prove correct, could cause its results to differ materially from those expressed or implied by such forward-looking statements. Although Acutus Medical forward-looking statements reflect the good faith judgment of its management, these statements are based only on facts and factors currently known by Acutus Medical.  As a result, you are cautioned not to rely on these forward-looking statements.

For More Information, please contact:
Acutus Medical
Mr. Randy Werneth
CEO / President
Randy.Werneth@acutusmedical.com


'/>"/>
SOURCE Acutus Medical, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Haemonetics Signs Definitive Agreement To Acquire Hemerus Medical, LLC
2. ConvaTec Announces Acquisition of AbViser Medical, LLC
3. ICU Medical, Inc. Plans to "Vigorously Seek to Collect Damages" in wake of Patent Infringement Victory Over RyMed Technologies
4. TriReme Medical, Inc. Receives FDA Approval for Glider™ PTCA Catheter
5. Nonin Medical, Inc. Announces U.S. Market Release of EQUANOX™ Advance Model 8004CB Series Sensor for Neonatal, Pediatric Patients
6. NexGen Biomedical, Inc. Provides New Insights Into Jett Travoltas Seizure Related Death
7. Cook Medical, Zimmer, Pro-Dex & J&J to Share Innovative Social Media Approaches to Marketing Device Products in Minneapolis
8. BioDrain Medical, Inc. Implements Initiatives to Position Itself for Sustained Growth
9. Solta Medical, Inc. Announces Proposed Public Offering of Common Stock
10. Solta Medical, Inc. Prices $15 Million Public Offering of Common Stock
11. Solta Medical, Inc. Closes Public Offering of Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... Companion animal vaccines ... pets such as canine, avian and feline. ... such as Attenuated Live Vaccines, Conjugate Vaccines, Inactivated ... Recombinant Vaccines. Attenuated live vaccines are derived from ... have been weakend under laboratory conditions. Conjugate vaccines ...
(Date:4/18/2017)... , April 18, 2017 Cogentix Medical, Inc. ... providing the Urology, Uro/Gyn and Gynecology markets with innovative ... first quarter ended March 31, 2017 after the market ... The Company will host a conference call and webcast ... Tuesday, May 2, 2017 at 4:30 p.m. Eastern Time ...
(Date:4/18/2017)... SUNNYVALE, Calif. , April 18, 2017 /PRNewswire/ ... results of collaboration started in 2016, in which ... "Artificial Brain SOINN". The companies achieved initial results ... ultrasound solution by Artificial Brain SOINN. The results ... Tokyo Big Sight, April 19-21, at booths 4505 ...
Breaking Medicine Technology:
(Date:4/24/2017)... ... April 24, 2017 , ... Salus ... announces the company’s VideoMedicine mobile platform has launched Quick Care, a new service ... day, Quick Care provides patients with the option to request and begin a ...
(Date:4/24/2017)... IL (PRWEB) , ... April 24, 2017 , ... Rod ... the Senior Housing News website. , Rod has been at the forefront of Gardant ... company’s culture. As CEO, Rod has overseen the opening of more than 40 new ...
(Date:4/24/2017)... ... , ... Donna Parker, L. Ac. reads all sorts of books on ... be very practical. She wanted to write a guide/workbook that would give readers step-by-step ... prompted her in writing “ A Clear Path to a Vibrant Life : 7 ...
(Date:4/24/2017)... ... April 24, 2017 , ... Miami ... attending the 2017 Oral Reconstruction Foundation’s 2017 Symposium on Tissue Regeneration and Implant ... will present its annual Global Symposium at the Fontainebleau Hotel located in Miami ...
(Date:4/23/2017)... ... April 23, 2017 , ... "An event Horizon is ... the process rendered in my Art and Music. These are created as Metaphysical Transformations ... the boundary of mystery culminate to the ultimate singularity.", -- Karen Salicath Jamali , ...
Breaking Medicine News(10 mins):